Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -325.57%-52.84K | 33.23%-63.39K | -372.98%-98.15K | 48.24%-152.51K | -803.14%-116.95K | 107.32%23.43K | -94.94K | 304.93%35.95K | -326.02%-294.63K | -49.63%16.63K |
| Net income from continuing operations | 109.87%15.39K | -118.15%-62.08K | -65.56%-100.02K | 80.13%-311.28K | 25.73%-66.45K | 89.53%-155.96K | ---28.46K | -568.23%-60.41K | -689.51%-1.57M | -143.24%-89.47K |
| Operating gains losses | -529.99%-78.85K | -71.79%3.28K | 75.21%25.1K | -104.16%-68.16K | -135.80%-81.58K | -100.89%-12.52K | --11.61K | 708.92%14.33K | 725.26%1.64M | 223.87%227.88K |
| Remuneration paid in stock | ---- | ---- | ---- | --110.48K | --0 | ---- | ---- | ---- | --0 | --0 |
| Deferred tax | ---- | ---- | ---- | 125.26%76K | 145.24%76K | ---- | ---- | ---- | -3,242.63%-300.84K | -1,766.67%-168K |
| Other non cashItems | -24.98%2.86K | ---- | ---- | -75.52%17.74K | --0 | -92.28%3.82K | --7K | -63.58%6.93K | -43.86%72.46K | -92.07%4.05K |
| Change In working capital | -90.00%7.76K | 92.40%-6.46K | -130.93%-23.23K | 116.53%22.71K | -206.51%-44.92K | 150.14%77.61K | ---85.09K | 402.72%75.11K | -553.76%-137.42K | 454.00%42.18K |
| -Change in receivables | -130.87%-1.37K | 30.07%-1.5K | -98.34%194 | 540.94%36.76K | -61.85%22.81K | 107.77%4.43K | ---2.15K | 204.90%11.67K | 56.36%-8.34K | 365.72%59.78K |
| -Change in prepaid assets | 166.18%34.78K | -85.16%2.58K | -2.23%-53.47K | 246.27%7.76K | 1,840.81%29.58K | -81.63%13.07K | 77.65%17.42K | 34.81%-52.3K | -67.46%2.24K | -97.17%1.52K |
| -Change in payables and accrued expense | -145.58%-29.84K | 89.66%-11.49K | -73.57%30.07K | 83.39%-21.81K | -136.37%-89.92K | 140.96%65.47K | ---111.12K | 70.95%113.76K | -408.98%-131.32K | 12.12%-38.04K |
| -Change in other working capital | 178.25%4.19K | -63.37%3.94K | -101.31%-26 | ---- | ---- | ---5.36K | --10.76K | --1.99K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -325.57%-52.84K | 33.23%-63.39K | -372.98%-98.15K | 48.24%-152.51K | -803.14%-116.95K | 107.32%23.43K | ---94.94K | 304.93%35.95K | -295.95%-294.63K | -68.64%16.63K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 721.38%273.54K | -124.01%-26.88K | -153.32%-28.57K | -100.65%-42.53K | 86.18%-40.08K | -100.65%-44.02K | -12K | 53.58K | 4,401.81%6.5M | -290K |
| Net business purchase and sale | --282.59K | ---- | ---- | 97.92%-5K | ---5K | --0 | ---- | ---- | -5,354.55%-240K | ---- |
| Net investment property transactions | 82.07%-7.89K | 38.81%-7.34K | -87.58%-11.13K | -101.41%-97.04K | -100.51%-35.08K | -147.03%-44.02K | ---12K | ---5.93K | 11,353.57%6.87M | --6.89M |
| Net investment purchase and sale | ---1.16K | --18.96K | 65.13%-17.44K | ---50K | --0 | --0 | --0 | ---50K | --0 | --0 |
| Net other investing changes | --0 | ---- | ---- | 187.61%109.51K | --0 | --0 | --0 | --109.51K | -18.22%-125K | ---785.31K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 721.38%273.54K | -124.01%-26.88K | -153.32%-28.57K | -100.65%-42.53K | 96.89%-40.08K | -100.56%-44.02K | ---12K | --53.58K | 4,401.81%6.5M | ---1.29M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -263.42%-58.01K | 16.73%-39.4K | 883.38%314.67K | 100.74%45.04K | 135.10%148.49K | 99.74%-15.96K | -47.31K | 7.97%-40.17K | -34,796.00%-6.06M | 203.90%63.16K |
| Net issuance payments of debt | 28.62%-18.78K | 26.39%-35.08K | 1,444.63%369.98K | 100.10%4.18K | 79.20%105.65K | 99.40%-26.3K | ---47.65K | 62.78%-27.52K | -9,983.38%-4.39M | 180.55%58.96K |
| Cash dividends paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---1.52M | --0 |
| Net other financing activities | -479.48%-39.24K | -1,378.40%-4.32K | -337.09%-55.31K | 128.20%40.86K | -95.73%42.84K | 100.88%10.34K | --338 | -141.79%-12.65K | -337.71%-144.91K | 7,992.53%1M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -263.42%-58.01K | 16.73%-39.4K | 883.38%314.67K | 100.74%45.04K | -86.03%148.49K | 99.77%-15.96K | ---47.31K | 7.97%-40.17K | -34,796.00%-6.06M | 1,849.02%1.06M |
| Net cash flow | ||||||||||
| Beginning cash position | 18.32%85.11K | -5.04%214.78K | -84.83%26.82K | 613.18%176.82K | -90.86%35.37K | 821.11%71.93K | 2,367.48%226.18K | 613.18%176.82K | 204.43%24.79K | 1,088.73%387.03K |
| Current changes in cash | 544.99%162.68K | 15.94%-129.67K | 280.76%187.95K | -198.67%-150K | 95.93%-8.55K | -109.21%-36.56K | ---154.25K | 241.98%49.36K | 813.12%152.03K | -2,607.12%-210.21K |
| End cash Position | 600.54%247.79K | 18.32%85.11K | -5.04%214.78K | -84.83%26.82K | -84.83%26.82K | -90.86%35.37K | 821.11%71.93K | 2,367.48%226.18K | 613.18%176.82K | 613.18%176.82K |
| Free cash from | -325.57%-52.84K | 33.23%-63.39K | -372.98%-98.15K | 48.24%-152.51K | -803.14%-116.95K | 107.32%23.43K | ---94.94K | 304.93%35.95K | -295.95%-294.63K | -68.64%16.63K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.